Sai Life Sciences IPO Sales, Profits, and other Financial Details - What you should know about the Sai Life Sciences IPO

Sai Life Sciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Financial Information of Sai Life Sciences Limited IPO
The revenues from operations for Fiscals ended 2024, 2023 and 2022 were ₹14,942.69 Million, ₹12,451.05 Million and ₹8,977.41 Million respectively. The EBITDA for Fiscals ended 2024, 2023 and 2022 were ₹2,881.55 Million, ₹1,864.78 Million, and ₹1,459.58 Million, respectively. The profit after tax for Fiscals ended 2024, 2023 and 2022 were ₹828.09 Million, ₹99.89 Million, and ₹62.26 Million respectively.

Sai Life Sciences Limited Financial Information (Restated Consolidated)

Amount in (₹ in Million)

Period Ended	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Reserve of Surplus	9,570.94	8,700.83	8,606.22
Total Assets	22,751.36	21,866.48	21,642.30
Total Borrowings	7,101.63	6,992.29	7,513.18
Fixed Assets	9,263.55	7,776.15	7,429.03
Cash	236.57	699.12	1,159.39
Net Borrowing	6,865.06	6,293.17	6,353.79
Revenue	14,942.69	12,451.05	8,977.41
EBITDA	2,881.55	1,864.78	1,459.58
PAT	828.09	99.89	62.26
EPS	4.53	0.55	0.34

Note 1:- RoE & ROCE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after Completion of the Offer, given in FINANCIAL EXPRESS.